MYC and hepatocellular carcinoma: Furthermore, some combinations of genetic alterations showed low/no tumour penetrance in our GEMMs, for example, Trp53 modifications in combination with MYC overexpression, while these showed high penetrance in HCC in previous models using hydrodynamic tail vein injections12.